CM
At a glance
Registered since
2024
Senate LDA system
Clients
36
last 3 years
Filings
102
6 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Sen. Bill Nelson
Deputy Legislative Director & Health Counsel
2015-2018); Rep. Sandy Levin, Legislative Counsel (2013-2015), Legislative Correspondent, Staff Assistant (2008-2009); House Committee on Ways and Means, Legal Clerk/Intern (2010
Disclosed on LD-2 filings
Career
TC
Specific issues
Issues related to IP protection under Bayh Dole; Issues related to implementation of drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169).
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA.
Issues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing).
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA, Consolidated Appropriations Act, 2023 (PL 117-328).
Issues related to the implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169).
Clients
Filing history
BRISTOL MYERS SQUIBB
BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
ASTELLAS PHARMA US, INC.
MERCK & CO., INC
ACADIA PHARMACEUTICALS, INC.
INCYTE CORPORATION
PHRMA
AMGEN INC
EMD SERONO, INC.
ASTRAZENECA
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)